Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 138.23 +0.24 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $137.99 | 52 Week High | $0.52 | |||
| Open | $134.10 | 52 Week Low | $0.08 | |||
| Day High | $144.20 | P/E | N/A | |||
| Day Low | $133.86 | EPS | $-3.80 | |||
| Volume | 14,591,724 | |||||
